Sanofi (SAN) Given a €81.00 Price Target by Berenberg Bank Analysts

Berenberg Bank set a €81.00 ($100.00) target price on Sanofi (EPA:SAN) in a research report report published on Wednesday. The firm currently has a neutral rating on the stock.

Several other equities analysts have also recently commented on the stock. Cfra set a €70.00 ($86.42) price target on shares of Sanofi and gave the company a neutral rating in a research report on Monday, February 12th. Societe Generale set a €94.00 ($116.05) price target on shares of Sanofi and gave the company a buy rating in a research report on Thursday, February 8th. Deutsche Bank set a €93.00 ($114.81) price target on shares of Sanofi and gave the company a buy rating in a research report on Thursday, February 8th. Credit Suisse Group set a €95.00 ($117.28) price target on shares of Sanofi and gave the company a buy rating in a research report on Thursday, February 8th. Finally, Sanford C. Bernstein set a €82.00 ($101.23) price target on shares of Sanofi and gave the company a neutral rating in a research report on Wednesday, February 7th. One analyst has rated the stock with a sell rating, eleven have issued a hold rating and five have issued a buy rating to the company. The company has an average rating of Hold and an average target price of €82.82 ($102.25).

Sanofi (EPA:SAN) opened at €64.50 ($79.63) on Wednesday. Sanofi has a 1 year low of €63.09 ($77.89) and a 1 year high of €92.97 ($114.78). The company has a market cap of $81,470.00 and a P/E ratio of 21.36.

ILLEGAL ACTIVITY WARNING: “Sanofi (SAN) Given a €81.00 Price Target by Berenberg Bank Analysts” was originally posted by BBNS and is owned by of BBNS. If you are viewing this story on another site, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this story can be read at https://baseballnewssource.com/markets/sanofi-san-given-a-81-00-price-target-by-berenberg-bank-analysts/1887284.html.

About Sanofi

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company’s pharmaceuticals operations.

Analyst Recommendations for Sanofi (EPA:SAN)

Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Cubs Sign Free Agent Yu Darvish
Cubs Sign Free Agent Yu Darvish
Mother of Pittsburgh Pirates Player Elias Diaz Has Been Kidnapped
Mother of Pittsburgh Pirates Player Elias Diaz Has Been Kidnapped
Giants Will Retire No. 25 of Barry Bonds in August
Giants Will Retire No. 25 of Barry Bonds in August
Mookie Betts Awarded Arbitration of $10.5 Million
Mookie Betts Awarded Arbitration of $10.5 Million


Leave a Reply

 
© 2006-2018 BBNS.